Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

DNA testing in Nigeria is moving beyond the courtroom and family disputes, as DemyHealth Clinic and Genomic Medicine introduced advanced sequencing ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

An updated edition of the July 30, 2025, article. Genomics involves a thorough study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). It involves understanding how genes ...

“Woodrats are remarkable in their ability to eat truly awful, toxic plants,” she says. “If there are no other options, ...

Often referred to as the ‘gold of the North’, Baltic amber serves as an exceptional natural time capsule, preserving a ...

Woodrats reveal how herbivores balance eating toxic plants and survival, offering insights into ecosystems and adaptation.

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

Global in-vitro diagnostics market valued at US$ 113.3 Bn in 2024, forecasted to grow at 6.1% CAGR and surpass US$ 216.9 Bn by 2035.

The global transcriptomics market size was US$ 6201.6 million in 2021. The global transcriptomics market size is forecast to reach US$ 11497.7 million by 2030, growing at a compound annual growth rate ...

Dr. Labidi-Galy received her medical degree from the University of Tunis and trained as a medical oncologist in Tunisia and France before pursuing a PhD in onco-immunology at the University of Lyon ...